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Abstract 
 
Background: Non-syndromic cleft lip with or without cleft palate (CL/P) or cleft palate only (CPO) are orofacial 
clefts with multifactorial etiology. These include environmental factors and heterogeneous genetic background. 
Therefore, studies on different and homogenous populations can be useful in detecting related factors. The aim 
of the present study was to evaluate the risk factors in patients with non-syndromic cleft in Tehran, Iran. 
 
Methods: Data from 300 patients and 300 controls were collected between 2005 and 2010. Binary logistic re-
gression analyses were used to calculate relative risk by odds ratio (OR) and %95 confidence interval. 
 
Results: Low maternal age (OR=1.06, 95% CI, 1.011-1.113), low socioeconomic status (OR=0.23, 95% CI, 
0.007-0.074), maternal systemic disease (OR=0.364; 95% CI, 0.152-0.873) and passive smoking (OR=0.613, 
95% CI, 0.430-0.874) increased the risk for CL/P and CPO. There was a significant difference in iron and folic 
acid use during pregnancy when the case and control groups were compared. 
 
Conclusion: In assessing for orofacial cleft risk, we should consider lack of folic acid supplementation use, 
maternal age and systemic diseases and passive smoking as risk factors. 
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Introduction 
 
Orofacial clefts are among the most common types of 
major birth defects, occurring in an estimated 1.5 to 2 
per 1000 births.
1 In the United States, approximately 
7500 infants are born with cleft malformation each 
year, subdivided anatomically into cleft lip with or 
without cleft palate (CL/P) and cleft palate only 
(CPO).
2  Researchers have proposed several theories 
to explain the origin of oral cleft. These include envi-
ronmental factors and heterogeneous genetic back-
ground (single genes, gene-gene interactions and 
gene-environment interactions). Therefore, studies on 
different and homogenous population can be useful in 
detecting potentially related environmental and genet-
ic factors.
3-6 
The aim of the present study was to evaluate whether 
many factors such as pregnancy exposure (smoking, 
medication, vitamin supplementation, x-ray), familial 
history and demographic characteristics were associated 
with specific types of cleft in a group of patients affect-
ed by non-syndromic clefts in Tehran, Iran. 
 
 
Materials and Methods 
 
A hospital-based case-control study was performed in 
Tehran, Capital of Iran. Cases were patients with 0-48 
months of age presenting CL/P or CPO not associated 
with any other birth defects or syndrome (non-
syndromic oral cleft). All cases were chosen from 
Bahrami Hospital, "a reference Pediatric Surgery Unit 
for orofacial clefts treatment” during 2005-2010. 
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Controls were a random sample of patients admit-
ted to the same hospital without any birth defects or 
systemic disease. Mothers of both case patients and 
controls were interviewed in the hospital by the same 
investigators. The standardized questionnaire was 
used to investigate information on the demographic 
characteristics, socioeconomic status, mother's medi-
cal history and pregnancy exposure including tobacco 
use (active and passive), radiation, folic acid and iron 
use during pregnancy.  
The interview included detailed questions on to-
bacco use. All mothers were asked whether they ever 
smoked and if so, whether they have smoked ciga-
rettes any time from 3 months before pregnancy until 
delivery. Mothers who reported any smoking in this 
period were asked specifically whether they smoked 
during these periods: 3 months before pregnancy, and 
the first, second and third trimester of pregnancy. 
Mothers were also asked to report the number of ciga-
rettes smoked daily during each of these periods. 
Moreover, mothers were asked about their exposure 
to environmental tobacco smoke (ETS) at home or 
work during pregnancy. Our assessment of ETS was 
limited to non-smoking mothers, defined as mothers 
who reported no active smoking. Analysis was limited 
to mothers who completely answered all questions. 
The research protocol was reviewed and approved 
by Ethical Committee of Shahid Beheshti University 
of Medical Sciences. The association between oral 
clefts (CL/P and CPO) and variables including sex, 
maternal age, maternal education, socioeconomic sta-
tus, pregnancy exposure, maternal systemic diseases 
and consanguinity was assessed by binary logestic 
regression model. 
We estimated odds ratios to evaluate the strength 
of association. To assess goodness of model, Hosmer 
and Lemeshow test was used. %95 confidence inter-
val (CI) for odds ratios associated with explanatory 
variables was considered. Regarding the special dis-
tribution of the two variables of folic acid use and 
familial history, association between these variables 
and risk for oral cleft was evaluated using Chi-Square 
test. In this investigation, type I error was considered 
as α=5%. 
 
 
Results 
 
The study included 300 cases of non-syndromic cleft 
and 300 healthy controls with no birth defects. The 
distribution of demographic and socioeconomic fac-
tors, pregnancy exposure, and familial history of cleft 
and maternal systemic disease of both groups were 
presented in Table 1. 
196 (65.3%) of the cases had CL/P, while 104 
(35.7%) cases had CPO. Among patients with CL/P, 
68 (22.6%) cases had bilateral cleft, 81 (27%) cases 
had left unilateral cleft, 44 (14.4%) cases had right uni-
lateral cleft and 3 (1%) cases had central cleft. In CPO 
patients, 83 (27.3%) cases had complete cleft, while 21 
(7.7%) cases had incomplete cleft. 104 males and 92 
females were in the CL/P group whereas the CPO 
group consisted of 50 males and 54 females. There 
were no significant differences between the case and 
control group patients with respect to sex, maternal 
smoking, X-Ray exposure, consanguinity and medica-
tion use (p>0.05 for all variables) (Table 2). 
All mothers who had reported smoking were ex-
smoker in both groups. The proportion who smoked 
was 2.3% (7 cases) for cases and 1.7% (5 cases) for 
controls. Both CL/P and CPO were associated with 
low maternal age (p=0.016), low maternal education 
(p=0.017), low economic status (p=0.001) and mater-
nal systemic disease (p=0.024). 
There was an inverse relation (OR= 0.43; 95% CI, 
0.286-0.727) between iron use during pregnancy and 
risk of oral cleft (p=0.001). There was also an associ-
ation between familial history of oral cleft and risk of 
both CL/P and CPO with the same overall risk 
(p<0.01). Furthermore, data analysis showed a signif-
icant difference (p<0.001) in acid folic use between 
case and control group. Daily use was approximately 
7% lower among mothers in the case group which 
was associated with the increased risk of CL/P and 
CPO. 
Among non-smoking mothers with exposure to 
any ETS at home or work during pregnancy, the odds 
ratio was 1.59 with a cleft defect compared to those 
who did not (OR=0.63; %95 CI, 0.43-0.84). No dose 
information was available to quantify the level of 
ETS exposure. 
 
 
Discussion 
 
Epidemiological studies on different populations are 
important for detecting different genetic groups and 
for demonstrating the role of environmental factors in 
different geographical areas.
7-9 
Any factor that could prevent the facial processes 
from reaching each other by slowing down migration, 
multiplication or both of neural crest cells by stopping  
 Orofacial clefts risk factors 
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Table 1: Prevalence of clinical charactristcs (and percent) of predisposing factors of orofacial 
Characteristics Case Control
Sex 
Boy 
Girl 
Maternal age at delivery 
<20 
20-23 
24-27 
28-31 
32-34 
>34 
Maternal education 
Illiterate 
Primary school 
High school 
Diploma 
University 
Parental consanguinity 
Yes 
No 
X- Ray exposure 
Yes 
No 
Monthly salary (Dollar) 
>250 
250-400 
401-550 
<550 
Iron use 
Daily use 
No use 
Unknown 
Folic acid use 
Daily use 
No use 
Supplemental vitamin use 
Daily use 
No use 
Systemic disease 
Yes 
No 
Mother employment status 
Yes 
No  
Father employment status 
Yes 
No  
Maternal smoking 
Mother never smoked 
ex-smoker 
Passive smoking 
Yes 
No 
History of familial cleft
a 
Yes 
No 
 
156 (52%) 
144 (48%) 
 
28 (9.3%) 
58 (19.3%) 
127 (42.3%) 
 79 (26.3%) 
 5 (1.7%) 
 3 (1%) 
 
 7 (2.3%) 
 71 (23.7%) 
107 (35.7%) 
110 (36.7%) 
 5 (1.7%) 
 
 34 (11.3%) 
 266 (88.7%) 
 
 7 (2.3%) 
 293 (97.7%) 
 
 74 (27.7%) 
 203 (67.7%) 
 18 (6%) 
 5 (1.7%) 
 
 241 (80.3%) 
 59 (19.7%) 
 - 
 
 281 (93.7%) 
 19 (6.3%) 
 
 245 (81.7%) 
 55 (18.3%) 
 
 18 (6%) 
 282 (94%) 
 
42 (14%) 
 258 (86%) 
 
 284 (94.7%) 
 16 (5.3%) 
 
 293 (97.7%) 
 7 (2.3%) 
 
 113 (37.7%) 
 187 (62.3%) 
 
 10 (3%) 
 290 (97%) 
 
169 (%56.3) 
131 (%43.7) 
 
 20 (%6.7) 
 38 (%12.7) 
 131 (%43.7) 
 95 (%31.7) 
 7 (%2.3) 
 9 (%3) 
 
 3 (%1) 
 54 (%18) 
 83 (%27.7) 
 146 (%48.7) 
 14 (%4.7) 
 
 25 (%8.3) 
 275 (%91.7) 
 
 8 (%2.7) 
 292 (%97.3) 
 
 22 (%7.3) 
 181 (%60.3) 
 69 (%23) 
 28 (%9.3) 
 
 202 (%67.3) 
 68 (%22.7) 
 30 (%10) 
 
 297 (%99) 
 3 (%1) 
 
 267 (%89) 
 33 (%11) 
 
 8 (%2.7) 
 292 (%97.3) 
 
 29 (%9.7) 
 271 (%90.3) 
 
 295 (%98.3) 
 5 (%1.7) 
 
 295 (%98.3) 
 5 (%1.7) 
 
 80 (%26.7) 
 220 (%73.3) 
 
 0 (%0) 
 300 (%100) 
a Clefts, Bahrami Hospital Iran 2005-2010 Taghavi et al. 
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tissue growth and development for a time or by kill-
ing some cells that are already in that location, would 
cause a persistence of a cleft.
10 
Analysis of data in the present study in Iran 
showed that folic acid and iron intake during preg-
nancy would decrease the risk for orofacial cleft 
which is adjusted for most studies in this field,
11-13 but 
in contrast to Cziele and Hayes reports.
14-16 Further-
more, inverse relationship between folic acid intake 
and risk for orofacial cleft is supported by findings 
from a large case-control study in which folic acid 
antagonist (dihydrofolate reductase inhibitors) was 
shown to increase the risk for orofacial clefts.
17 
There are several lines of evidence suggesting the 
folate-hemocysteine metabolism to be implicated in 
the risk of orofacial clefts. However the explanation 
for this association is unknown but recent information 
shows endothelial nitric oxide synthase (NOS3) ge-
netic variants expressing NOS3 involvement in fo-
late- homocysteine metabolism which inhibits nitric 
oxide resulting in hypertension and fetal growth re-
tardation in pregnant rats.
17,18 
It has recently been observed that the different 
levels of endogenous nitric oxide in different time 
periods influenced the balance between cell cycle 
progression and programmed cell death in developing 
neural plate of thick embryos-cells that contribute to 
facial development.
17 So we can emphasize the pre-
ventive role of folic acid in oral cleft development. 
In consistent with Leite et al. study,
3  the present 
study showed that familial history of oral cleft was sig-
nificantly associated with both CL/P and CPO which 
can imply the role of genetic factors. Over the past dec-
ades, a considerable interest has developed in the identi-
fication of genes that contribute to the etiology of orofa-
cial cleft. The first candidate gene was transforming 
growth factor-a (TGF-A) which showed an association 
with non-syndromic cleft lip and palate.
19-21 
Evaluation of gene-environment interactions is still 
in its preliminary stage. Studies of role of smoking in 
TGF-A and MSx1 genes as covariates have suggested 
that the risk for orofacial clefting may be influenced by 
maternal smoking alone as well as combination with 
the presence of uncommon TGF-A allele.
18 With re-
spect to lack of association between maternal smoking 
and risk for orofacial cleft in this study in contrast to 
other studies,
4,5,17,20,22-24  the current data support the 
possibility that smoking has a different effect on cleft 
Table 2: Assessment of variables effect on orofacial cleft 
Variable   Adjusted OR P value
a
Demographic 
Sex
a  
Low maternal age
a 
Maternal education
a 
Illiterate 
Primary school 
High school 
Diploma 
university 
Socioeconomic status
a 
Monthly salary(Dollar) 
>250 
250-400 
401-550 
<550 
Pregnancy exposure
a 
Iron use 
Supplemental vitamin use 
X - Ray 
Medication  
Maternal smoking 
Passive smoking 
Maternal Systemic disease
a 
Consanguinity
b 
 
0.825 (0.593-1.147) 
1.06 (1.011-1.113) 
- 
- 
1.724 (0.419-7.092) 
1.662 (0.410-6.735) 
2.753 (0.685-11.059) 
5.306 (0.956-29.444) 
 
 
0.23 (0.007-0.074) 
0.84 (0.03-0240) 
0.488 (0.158-1.505) 
- 
 
0.435 (0.286-0.727) 
1.235 (0.693-2.208) 
1.16 (0.415-3.251) 
0.467 (0.201-1.088) 
1.516 (0.340-3.927) 
0.613 (0.430-0.874) 
0.364 (0.152-0.873) 
0.71 (0.412-1.223) 
 
0.25 
0.016 
0.017 
- 
0.451 
0.477 
0.056 
 
0.001 
- 
0.001 
0.001 
0.212 
- 
 
0.001 
0.474 
0.794 
0.078 
0.817 
0.007 
0.024 
0.217 
a Logestic regression model, Hosmer and Lemeshow goodness of fit P value=0.360.  
b Chi-square test, P value=0.217 Orofacial clefts risk factors 
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risk among women which may reflect a role for genetic 
susceptibility factors in cleft development. 
The current study showed ETS exposure increased 
the risk for orofacial cleft which was similar to other 
studies.
5,22-25  The proportion of non-smoking cases 
reporting ETS exposure was 38% which was higher 
than control mothers (26%). One limitation was our 
inability to quantify ETS exposure, but studies using 
cotinine levels of measured dose of ETS exposure 
have documented adverse outcome at the highest lev-
el of ETS exposure.
25,26 
Low socioeconomic status and low maternal educa-
tion seemed to be risk factors for having a child with 
orofacial clefts similar to Kraples et al. study.
25,26 In 
line with Kraples et al., we speculated that low socio-
economic status as a risk factor should be considered 
because it can be a marker of parental health and life 
style. Individuals with low education tend to smoke 
more and have less healthy diets and nutrients. The life 
style factors, either alone or combination with occupa-
tional activities and genetic background, play a role in 
the etiology of orofacial cleft. 
In line with other studies we have found that low 
maternal age at delivery
17,18 and maternal systemic dis-
ease increased risk for orofacial cleft.
25,26 However we 
encountered few limitations during recalling and inter-
viewing mothers, while the current study had some 
notable strength. The large sample size and the loca-
tion of the study enabled us to extend the results to Ira-
nian population because the center we chose was a re-
ferral center for orofacial cleft surgery. Furthermore, 
we evaluated approximately all of the risk factors that 
have been considered in other studies separately.
 27 
In conclusion, this study demonstrated the role of 
some environmental factors in this geographic area 
for orofacial cleft forming. It is known that passive 
smoking, lack of folic acid and iron use during preg-
nancy may play role in inducing cleft formation. 
Moreover, a statistically significant association be-
tween low maternal age and education, systemic dis-
eases and familial history of oral cleft and higher risk 
of CL/P and CPO was observed. 
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